Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Furoate and Oxymetazoline for Adenoid Hypertrophy with Allergic Rhinitis
NCT02559440Phase 4Completed
- Start
- Feb 2014
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of mometasone, oxymetazoline in adenoid hypertrophy, allergic rhinitis (AR). Started Feb 2014; status: completed.
02
Drugs
mometasoneoxymetazoline
03
Conditions
adenoid hypertrophyallergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02559440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02559440.